Fig. 3From: The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patientsGuideline-adherent treated patients of cohort 1996–97 and cohort 2003–04. Comparison of institutional-invasive (left) and regional-invasive samples (right)Back to article page